<DOC>
	<DOCNO>NCT00741949</DOCNO>
	<brief_summary>Fiberoptic bronchoscopy ( FOB ) important tool diagnosis pulmonary disease , particularly infectious pneumonia . In patient severe acute hypoxemic respiratory failure , FOB may contra-indicated patient intubate control oxygenation obtain . In literature several author show perform FOB non invasive ventilation ( NIV ) preserve oxygenation patient ; recent French Consensus NIV recommend perform FOB NIV patient acute hypoxemic respiratory failure . Nevertheless procedure remain uncomfortable patient respiratory failure . In addition , patient 's agitation may lead desaturation , compromise realization FOB .</brief_summary>
	<brief_title>Broncho-alveolar Lavage Under Noninvasive Ventilation With Propofol TCI Patient With AHRF</brief_title>
	<detailed_description>In acute hypoxemic respiratory failure , FOB BAL life threaten deep oxygen desaturation . Performing FOB NIV show efficient prevent episodes desaturation . Several mode ventilation try ; Continuous Positive Airways Pressure Pressure Support Ventilation show superiority compare oxygen supplementation alone . The recent French consensus NIV recommend perform FOB NIV hypoxemic condition . Efficacy NIV alter patient agitation asynchronism ventilator . Though , author propose use sedative agent like remifentanyl NIV . To knowledge , none study evaluate beneficial effect sedation FOB BAL NIV . Propofol anesthetic agent administer TCI , maintain constant concentration target cerebral compartment . Propofol widely use different type anesthesia . Using concept , author report use sedation , small target concentration . TCI sedation propofol preserve patient 's spontaneous ventilation , alter hemodynamic parameter . Our hypothesis sédation TCI propofol lead best oxygen saturation without intervention patient acute hypoxemic respiratory failure undergo FOB BAL NIV . Thus , design randomize control study . Eligible patient randomize two group . In treatment group , patient receive sedation propofol procedure FOB NIV . In group , patient receive placebo procedure . Patients fibroscopist wo n't aware randomization group</detailed_description>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Pulmonary Valve Insufficiency</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<criteria>Acute respiratory failure define clinical sign respiratory failure ( polypnea , use accessory respiratory muscle ) PaO2/FiO2 ratio &lt; 250 Need diagnosis FOB BAL Informed consent sign Contraindication NIV FOB bronchial biopsy Acute coronary syndrome Thrombopenia &lt; 30.000 / mm3 despite platelet transfusion Coagulation disorder PaO2/FiO2 ratio &lt; 80 NIV Persistent respiratory acidosis NIV ( pH &lt; 7,32 ) Propofol allergy Xylocaïne allergy Pregnancy Age &lt; 18 year &gt; 90 year Weight &gt; 150 kg &lt; 30 kg Inclusion another clinical protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Respiratory failure</keyword>
	<keyword>Target Controlled Infusion</keyword>
	<keyword>TCI</keyword>
	<keyword>Propofol</keyword>
	<keyword>Noninvasive ventilation</keyword>
	<keyword>Broncho-alveolar lavage</keyword>
</DOC>